Skip to main content
Erschienen in: Obesity Surgery 4/2012

01.04.2012 | Review

Bariatric Surgery: Cost-Effectiveness and Budget Impact

verfasst von: Lorenzo Terranova, Luca Busetto, Annarita Vestri, Marco Antonio Zappa

Erschienen in: Obesity Surgery | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Bariatric surgery is to date the most effective treatment for morbid obesity and it has been proven to reduce obesity-related comorbidities and total mortality. As any medical treatment, bariatric surgery is costly and doubts about its affordability have been raised. On the other hand, bariatric surgery may reduce the direct and indirect costs of obesity and related comorbidities. The appreciation of the final balance between financial investments and savings is critical from a health economic perspective. In this paper, we try to provide a brief updated review of the most recent studies on the cost-efficacy of bariatric surgery, with particular emphasis on budget analysis. A brief overview of the economic costs of obesity will also be provided. The epidemic of obesity may cause a significant reduction in life expectancy and overwhelming direct and indirect costs for citizens and societies. Cost-efficacy analyses included in this review consistently demonstrated that the additional years of lives gained through bariatric surgery may be obtained at a reasonable and affordable cost. In groups of patients with very high obesity-related health costs, like patients with type 2 diabetes, the use of bariatric surgery required an initial economic investment, but may save money in a relatively short period of time.
Literatur
1.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.PubMedCrossRef Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.PubMedCrossRef
2.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. A systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. A systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
3.
Zurück zum Zitat Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med. 2004;351:2683–93.CrossRef Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med. 2004;351:2683–93.CrossRef
4.
Zurück zum Zitat Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. A randomized controlled trial. JAMA. 2008;299:316–23.PubMedCrossRef Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. A randomized controlled trial. JAMA. 2008;299:316–23.PubMedCrossRef
5.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef
6.
Zurück zum Zitat MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213–20.PubMedCrossRef MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213–20.PubMedCrossRef
7.
Zurück zum Zitat Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.PubMedCrossRef Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.PubMedCrossRef
8.
Zurück zum Zitat Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.PubMedCrossRef Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.PubMedCrossRef
9.
Zurück zum Zitat Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3:496–502.PubMedCrossRef Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3:496–502.PubMedCrossRef
10.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef
11.
Zurück zum Zitat Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis. 2007;3:73–7.PubMedCrossRef Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis. 2007;3:73–7.PubMedCrossRef
12.
Zurück zum Zitat Peeters A, O’Brien PE, Laurie C, et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007;246:1028–33.PubMedCrossRef Peeters A, O’Brien PE, Laurie C, et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007;246:1028–33.PubMedCrossRef
13.
Zurück zum Zitat Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253:1–4.CrossRef Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253:1–4.CrossRef
14.
Zurück zum Zitat Finkelstein EA, Trogdon JG, Cohen JW, et al. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff. 2009;28:w822–31.CrossRef Finkelstein EA, Trogdon JG, Cohen JW, et al. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff. 2009;28:w822–31.CrossRef
15.
Zurück zum Zitat Powers KA, Rehrig ST, Jones DB. Financial impact of obesity and bariatric surgery. Med Clin North Am. 2007;91:321–8.PubMedCrossRef Powers KA, Rehrig ST, Jones DB. Financial impact of obesity and bariatric surgery. Med Clin North Am. 2007;91:321–8.PubMedCrossRef
16.
Zurück zum Zitat National Audit Office (NAO). Tackling obesity in England, HC 220. London: The Stationery Office; 2001. National Audit Office (NAO). Tackling obesity in England, HC 220. London: The Stationery Office; 2001.
17.
Zurück zum Zitat National Institute for Health and Clinical Excellence (NICE) Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE clinical guideline 43. Issue date: December 2006 National Institute for Health and Clinical Excellence (NICE) Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE clinical guideline 43. Issue date: December 2006
18.
Zurück zum Zitat Levi J, Vinter S, Richardson L, et al. F as in fat: how obesity policies are failing in America. Issue report. Princeton: Robert Wood Johnson Foundation; 2009. Levi J, Vinter S, Richardson L, et al. F as in fat: how obesity policies are failing in America. Issue report. Princeton: Robert Wood Johnson Foundation; 2009.
19.
Zurück zum Zitat Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol. 2004;29:90–115.PubMedCrossRef Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol. 2004;29:90–115.PubMedCrossRef
20.
Zurück zum Zitat Finkelstein EA, Derek S, Brown DS, et al. Individual and aggregate years-of-life-lost associated with overweight and obesity. Obesity. 2010;18:333–9.PubMedCrossRef Finkelstein EA, Derek S, Brown DS, et al. Individual and aggregate years-of-life-lost associated with overweight and obesity. Obesity. 2010;18:333–9.PubMedCrossRef
21.
Zurück zum Zitat Wang F, McDonald T, Bender J, et al. Association of healthcare costs with per unit body mass index increase. J Occup Environ Med. 2006;48:668–74.PubMedCrossRef Wang F, McDonald T, Bender J, et al. Association of healthcare costs with per unit body mass index increase. J Occup Environ Med. 2006;48:668–74.PubMedCrossRef
22.
Zurück zum Zitat Quesenberry Jr CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466–72.PubMedCrossRef Quesenberry Jr CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466–72.PubMedCrossRef
23.
Zurück zum Zitat Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31:S663–7.PubMedCrossRef Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31:S663–7.PubMedCrossRef
24.
Zurück zum Zitat Finkelstein EA, Ruhm CJ, Kosa KM. Economic causes and consequences of obesity. Annu Rev Public Health. 2005;26:239–57.PubMedCrossRef Finkelstein EA, Ruhm CJ, Kosa KM. Economic causes and consequences of obesity. Annu Rev Public Health. 2005;26:239–57.PubMedCrossRef
26.
Zurück zum Zitat Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff. 2002;21:245–53.CrossRef Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff. 2002;21:245–53.CrossRef
27.
Zurück zum Zitat Wadden TA, Sarwer DB, Fabricatore AN, et al. Psychosocial and behavioural status of patients undergoing bariatric surgery: what to expect before and after surgery. Med Clin North Am. 2007;91:451–69.PubMedCrossRef Wadden TA, Sarwer DB, Fabricatore AN, et al. Psychosocial and behavioural status of patients undergoing bariatric surgery: what to expect before and after surgery. Med Clin North Am. 2007;91:451–69.PubMedCrossRef
28.
Zurück zum Zitat Finkelstein EA, Brown DS. A cost–benefit stimulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care. 2005;11:641–6.PubMed Finkelstein EA, Brown DS. A cost–benefit stimulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care. 2005;11:641–6.PubMed
29.
Zurück zum Zitat Narbro K, Jonsson E, Larsson B, et al. Economic consequences of sick-leave and early retirement in obese Swedish women. Int J Obes. 1996;20:895–903. Narbro K, Jonsson E, Larsson B, et al. Economic consequences of sick-leave and early retirement in obese Swedish women. Int J Obes. 1996;20:895–903.
30.
Zurück zum Zitat Frezza EE, Wachtel MS, Ewing BT. The impact of morbid obesity on the state economy: an initial evaluation. Surg Obes Relat Dis. 2006;2:504–8.PubMedCrossRef Frezza EE, Wachtel MS, Ewing BT. The impact of morbid obesity on the state economy: an initial evaluation. Surg Obes Relat Dis. 2006;2:504–8.PubMedCrossRef
31.
Zurück zum Zitat Wolf AM, Colditz GA. The cost of obesity. The US perspective. Pharmacoecomomics. 1994;5:34–7.CrossRef Wolf AM, Colditz GA. The cost of obesity. The US perspective. Pharmacoecomomics. 1994;5:34–7.CrossRef
32.
Zurück zum Zitat Cawley J, Rizzo JA, Haas K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med. 2007;49:1317–24.PubMedCrossRef Cawley J, Rizzo JA, Haas K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med. 2007;49:1317–24.PubMedCrossRef
33.
Zurück zum Zitat Sjöström L, Larsson B, Backmann L, et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes. 1992;16:465–79. Sjöström L, Larsson B, Backmann L, et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes. 1992;16:465–79.
34.
Zurück zum Zitat Salem L, Devlin A, Sullivan S. Cost-effectiveness of laparoscopic gastric bypass, adjustable gastric banding, and non-operative weight-loss interventions. Surg Obes Relat Dis. 2008;4:26–32.PubMedCrossRef Salem L, Devlin A, Sullivan S. Cost-effectiveness of laparoscopic gastric bypass, adjustable gastric banding, and non-operative weight-loss interventions. Surg Obes Relat Dis. 2008;4:26–32.PubMedCrossRef
35.
Zurück zum Zitat Campbell J, McGarry L, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass in the treatment of morbid obesity. Am J Manag Care. 2010;16:e174–87.PubMed Campbell J, McGarry L, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass in the treatment of morbid obesity. Am J Manag Care. 2010;16:e174–87.PubMed
36.
Zurück zum Zitat Clegg A, Colquitt J, Sidhu M, et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes. 2003;27:1167–77.CrossRef Clegg A, Colquitt J, Sidhu M, et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes. 2003;27:1167–77.CrossRef
37.
Zurück zum Zitat Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(1–190):215–357. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(1–190):215–357.
38.
Zurück zum Zitat van Mastrigt GA, van Dielen FM, Severens JL, et al. One-year cost-effectiveness of surgical treatment of morbid obesity: vertical banded gastroplasty versus Lap-Band. Obes Surg. 2006;16:75–84.PubMedCrossRef van Mastrigt GA, van Dielen FM, Severens JL, et al. One-year cost-effectiveness of surgical treatment of morbid obesity: vertical banded gastroplasty versus Lap-Band. Obes Surg. 2006;16:75–84.PubMedCrossRef
39.
Zurück zum Zitat Fisher BL. Comparison of recovery time after open and laparoscopic gastric bypass and laparoscopic adjustable banding. Obes Surg. 2004;14:67–72.PubMedCrossRef Fisher BL. Comparison of recovery time after open and laparoscopic gastric bypass and laparoscopic adjustable banding. Obes Surg. 2004;14:67–72.PubMedCrossRef
40.
Zurück zum Zitat Nguyen N, Slone J, Nguyen XT, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity. Ann Surg. 2009;250:631–41.PubMed Nguyen N, Slone J, Nguyen XT, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity. Ann Surg. 2009;250:631–41.PubMed
41.
Zurück zum Zitat Encinosa WE, Bernard DM, Du D, et al. Recent improvements in bariatric surgery outcomes. Med Care. 2009;47:531–5.PubMedCrossRef Encinosa WE, Bernard DM, Du D, et al. Recent improvements in bariatric surgery outcomes. Med Care. 2009;47:531–5.PubMedCrossRef
42.
Zurück zum Zitat De Waele BD, Lauwers M, Van Nieuwenhove Y, et al. Outpatient laparoscopic gastric banding: initial experience. Obes Surg. 2004;14:1108–10.PubMedCrossRef De Waele BD, Lauwers M, Van Nieuwenhove Y, et al. Outpatient laparoscopic gastric banding: initial experience. Obes Surg. 2004;14:1108–10.PubMedCrossRef
43.
Zurück zum Zitat Montgomery KF, Watkins BM, Ahroni JH, et al. Outpatient laparoscopic adjustable gastric banding in super-obese patients. Obes Surg. 2007;17:711–6.PubMedCrossRef Montgomery KF, Watkins BM, Ahroni JH, et al. Outpatient laparoscopic adjustable gastric banding in super-obese patients. Obes Surg. 2007;17:711–6.PubMedCrossRef
44.
Zurück zum Zitat Watkins BM, Ahroni JH, Michaelson R, et al. Laparoscopic adjustable gastric banding in an ambulatory surgery center. Surg Obes Relat Dis. 2008;4:S56–62.PubMedCrossRef Watkins BM, Ahroni JH, Michaelson R, et al. Laparoscopic adjustable gastric banding in an ambulatory surgery center. Surg Obes Relat Dis. 2008;4:S56–62.PubMedCrossRef
45.
Zurück zum Zitat Wasowicz-Kemps DK, Bliemer B, Boom FA, et al. Laparoscopic gastric banding for morbid obesity: outpatient procedure versus overnight stay. Surg Endosc. 2006;20:1233–7.PubMedCrossRef Wasowicz-Kemps DK, Bliemer B, Boom FA, et al. Laparoscopic gastric banding for morbid obesity: outpatient procedure versus overnight stay. Surg Endosc. 2006;20:1233–7.PubMedCrossRef
46.
Zurück zum Zitat Segal JB, Clark JM, Shore AD, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009;19:1646–56.PubMedCrossRef Segal JB, Clark JM, Shore AD, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009;19:1646–56.PubMedCrossRef
47.
Zurück zum Zitat Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16:1488–503.PubMedCrossRef Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16:1488–503.PubMedCrossRef
48.
Zurück zum Zitat Anselmino M, Bammer T, Fernandez JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries (II). Obes Surg. 2009;19:1542–9.PubMedCrossRef Anselmino M, Bammer T, Fernandez JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries (II). Obes Surg. 2009;19:1542–9.PubMedCrossRef
49.
Zurück zum Zitat Keating CL, Dixon JB, Moodie ML, et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2009;32:580–4.PubMedCrossRef Keating CL, Dixon JB, Moodie ML, et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2009;32:580–4.PubMedCrossRef
50.
Zurück zum Zitat Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24–32.PubMed Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24–32.PubMed
Metadaten
Titel
Bariatric Surgery: Cost-Effectiveness and Budget Impact
verfasst von
Lorenzo Terranova
Luca Busetto
Annarita Vestri
Marco Antonio Zappa
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 4/2012
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0608-1

Weitere Artikel der Ausgabe 4/2012

Obesity Surgery 4/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.